Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin Treatment
Phase 3
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Registration Number
- NCT00213070
- Lead Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Brief Summary
The purpose of this study is evaluate the clinical efficacy and safety of Miglitol in patients with Type2 Diabetes Mellitus with treated insulin.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Type2 diabetes
- Criteria of postprandial plasma glucose and HbA1c are met
Read More
Exclusion Criteria
- Type1 diabetes
- Patients with antidiabetic drugs
- The other exclusion criteria are met
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method